Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2005
12/07/2005CN1230542C Production of proteins by autoproteolytic cleavage
12/07/2005CN1230538C Immunological reagent specifically interreacting with the extracellular domain of the human zeta chain
12/07/2005CN1230537C Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from fusion product in aspergillus
12/07/2005CN1230536C Tie-2 ligands, methods of making and uses thereof
12/07/2005CN1230535C Isolated peptides which form complexes with MHC molecule HLA-C-Clone 10 and uses thereof
12/07/2005CN1230529C Bacillus-derived transglutaminase
12/07/2005CN1230446C Antibodies and FV fragment recognizing antigen IORC2
12/07/2005CN1230445C Novel human protein with function for promoting mouse NIH/313 cell transformation and coding sequence thereof
12/07/2005CN1230201C Blood-platelet specific mosaic immune globulin and its using method
12/06/2005USH2136 Nucleic acids encoding G protein-coupled receptors
12/06/2005US6973388 Using computers
12/06/2005US6972322 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases
12/06/2005US6972282 Process for producing a product containing antihypertensive tripeptides
12/06/2005US6972186 Nucleic acid encoding pro 1410 polypeptides
12/06/2005US6972185 For use as pharmaceuticals, diagnostics, biosensors and bioreactors
12/06/2005US6972179 RRP sequences and knockout mice and uses thereof
12/06/2005US6972176 KVLQT1—a long QT syndrome gene
12/06/2005CA2285700C Renin-active substance
12/06/2005CA2073282C Human herpesvirus type 6 protein p100, the corresponding dna sequences, their preparation and use
12/01/2005WO2005114885A1 Methods and systems for issuing identity credentials, such as driver licenses
12/01/2005WO2005113782A1 Tc-83-derived alphavirus vectors, particles and methods
12/01/2005WO2005113775A1 Pproduction of a protein localized to the endoplasmic reticulum protein bodies in a transgenic plant and seed
12/01/2005WO2005113772A1 Fluorescent protein
12/01/2005WO2005113768A1 Process for producing polypeptide
12/01/2005WO2005113756A1 Method
12/01/2005WO2005113599A1 C1q family member proteins with altered immunogenicity
12/01/2005WO2005113592A2 Interferon-alpha polypeptides and conjugates
12/01/2005WO2005113583A1 An expression system comprising operably linked rgg gene and gtfg promoter
12/01/2005WO2005112979A2 Methods of preventing and treating alimentary mucositis
12/01/2005WO2005082930A3 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof
12/01/2005WO2005080545A3 Method for the production of recombined proteins in eukaryontic host cells
12/01/2005WO2005070967A3 Anti-cancer antibodies with reduced complement fixation
12/01/2005WO2005069975A3 Lysyl oxidase-like 1 (loxl1) and elastogenesis
12/01/2005WO2005062916A3 Methods for generating multimeric molecules
12/01/2005WO2005051977A3 Conditional allele system
12/01/2005WO2005019251A8 Novel fungal proteins and nucleic acids encoding same
12/01/2005WO2004113497A3 Gene delivery to tumors
12/01/2005WO2004094988A3 Tolerance to graft prior to thymic regeneration
12/01/2005WO2004094649A3 Tolerance to graft following thymic reactivation
12/01/2005WO2004082629A3 Novel cyclosporins
12/01/2005WO2004059556A3 Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein
12/01/2005WO2003049703A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/01/2005US20050268350 Identification and purification of higher order transcription complexes from transgenic non-human animals
12/01/2005US20050266552 Reagents and methods for identification of RNAi pathway genes and chemical modulators of RNAi
12/01/2005US20050266550 TC-83-derived alphavirus vectors, particles and methods
12/01/2005US20050266544 Methods and compositions for increasing viral vector production in packaging cell lines
12/01/2005US20050266531 For selectively inhibiting the proliferation of stellate cells, which are important for the development of liver fibrosis upon liver injury
12/01/2005US20050266526 Glycoprotein synthesis
12/01/2005US20050266524 Beta integrin gene and protein
12/01/2005US20050266522 Human amine receptor
12/01/2005US20050266521 Production method for iturin a and its homologues
12/01/2005US20050266519 Methods and compositions for modulating and detecting activin dimer and dimer formation
12/01/2005US20050266515 Glyceraldehyde 3-phosphate dehydrogenase-S (GAPDHS), a glycolytic anzyme expressed only in male germ cells, is a target for male contraception
12/01/2005US20050266506 Method for diagnosing or monitoring carbohydrate metabolism disorders
12/01/2005US20050266486 Methods for treating obesity by inhibiting expression of obese gene product receptor variant
12/01/2005US20050266485 polynucleotides encoding a hematopoietic cytokine receptor polypeptide, for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs; test detecting a genetic disorder, cancer
12/01/2005US20050266484 gene therapy; a sequence which encodes the polypeptide podocin; proteinuria
12/01/2005US20050266479 Cloning, expression and characterization of the SPG4 gene responsible for the most common form of autosomal dominant spastic paraplegia
12/01/2005US20050266477 Reagents and methods useful for detecting diseases of the gastrointestinal tract
12/01/2005US20050266473 Reconstituted histone methyltransferase complex and methods of identifying modulators thereof
12/01/2005US20050266471 Common marmoset-derived beta-actin gene and use thereof
12/01/2005US20050266470 25501, a human transferase family member and uses therefor
12/01/2005US20050266469 Alternatively spliced isoforms of checkpoint kinase 1 (CHK1)
12/01/2005US20050266465 Interferon-alpha polypeptides and conjugates
12/01/2005US20050266464 C1q family member proteins with altered immunogenicity
12/01/2005US20050266461 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/01/2005US20050266457 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms
12/01/2005US20050266454 Polypeptide comprising myosin kinase activity for as use tool in identifying modulators for treatment of metabolic disorders
12/01/2005US20050266445 Purified mammalian CTLA-8 antigens and related reagents
12/01/2005US20050266443 Novel tumor suppressor gene and compositions and methods for making and using the same
12/01/2005US20050266440 genetic engineered plants, whose cells are transfected with recombinant nucleic acid molecules that code a polyketide synthases for the production of polyunsaturated fatty acids (PUFAs); trangenic plants
12/01/2005US20050266437 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
12/01/2005US20050266430 A mutated G-CSF mRNA or cDNA fragment having a deletion of an exon 3 region for use; primer for use in amplification of a G-CSF gene
12/01/2005US20050266425 Methods for producing and identifying multispecific antibodies
12/01/2005US20050266423 Novel nucleic acids and polypeptides
12/01/2005US20050266421 Claudin polypeptides, polynucleotides, and methods of making and use thereof
12/01/2005US20050266412 Method of amplifying infectious protein
12/01/2005US20050266017 Plasmodium falciparum antigens inducing protective antibodies
12/01/2005US20050266013 Diagnosis of RH factor; using polypeptides to form antibodies; purified polypeptide capable of forming antigen binding structures with specificity for Rhesus D antigens for treating idiopathic thrombocytopenic purpura (ITP) or mistransfusion of Rhesus incompatible blood
12/01/2005US20050266002 Methods for the treatment of cancer using anti-CD40 antibodies
12/01/2005US20050265988 Glycosylated glucocerebrosidase expression in fungal hosts
12/01/2005US20050262765 Floral packaging material having great masters prints thereon
12/01/2005CA2567501A1 An expression system comprising operably linked rgg gene and gtfg promoter
12/01/2005CA2567496A1 C1q family member proteins with altered immunogenicity
12/01/2005CA2567272A1 Transgenic plants expressing intein modified proteins and associated processes for bio-pharmaceutical production
12/01/2005CA2566439A1 Methods of preventing and treating alimentary mucositis
12/01/2005CA2566247A1 Interferon-alpha polypeptides and conjugates
12/01/2005CA2565014A1 Isolated nucleic acid molecules encoding a novel phosphoprotein-darpp-32, encoded protein and uses thereof
12/01/2005CA2563702A1 Probiotic compounds from lactobacillus gg and uses therefor
11/2005
11/30/2005EP1600505A1 Escherichia coli phytase
11/30/2005EP1599596A2 Combinatorial dna library for producing modified n -glycans in lower eukaryotes
11/30/2005EP1599595A2 N -acetylglucosaminyltransferase iii expression in lower eukaryotes
11/30/2005EP1599579A1 Translocating enzyme used as a selection marker
11/30/2005EP1599578A2 Methods for preventing gluconoylation of proteins
11/30/2005EP1565557A4 Mismatch endonucleases and methods of use
11/30/2005EP1523574A4 Modular recombinatorial display libraries
11/30/2005EP1430131B1 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
11/30/2005EP1335932B1 Isolation of lectins
11/30/2005EP1252179B1 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them
11/30/2005EP1196586B1 Basb111 polypeptide and polynucleotide from moraxella catharrhalis
1 ... 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 ... 1125